Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Short term Debt: 2012-2021

Historic Short term Debt for Altimmune (ALT) over the last 4 years, with Dec 2021 value amounting to $6.1 million.

  • Altimmune's Short term Debt was N/A to $4.3 million in Q1 2022 from the same period last year, while for Mar 2022 it was $4.3 million, marking a year-over-year change of. This contributed to the annual value of $6.1 million for FY2021, which is N/A change from last year.
  • According to the latest figures from FY2021, Altimmune's Short term Debt is $6.1 million, which was up 716.19% from $746,146 recorded in FY2014.
  • Over the past 5 years, Altimmune's Short term Debt peaked at $6.1 million during FY2021, and registered a low of $6.1 million during FY2021.
  • For the 1-year period, Altimmune's Short term Debt averaged around $6.1 million, with its median value being $6.1 million (2021).